Form 4: NRC Health Director Receives Equity Award

NRC Health Director John N. Nunnelly was granted restricted stock units valued at $150,000, vesting in 2027.

Summary

• John N. Nunnelly, a Director at NRC Health, received an equity award on June 23, 2026.
• The award consists of restricted stock units (RSUs) with a value of $150,000.
• The number of RSUs granted was calculated by dividing $150,000 by the closing stock price on the day before the Issuer's 2026 annual meeting.
• These RSUs are part of the Issuer's 2025 Omnibus Incentive Plan.
• The award is subject to vesting, forfeiture, and termination provisions.
• The RSUs will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting.
• Following this transaction, Nunnelly beneficially owns 40,363 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting standard compensation practices for a director rather than significant company performance news.

Positives

• Director receives a significant equity award ($150,000) as compensation, indicating alignment with long-term company performance.
• The award is part of a formal incentive plan, suggesting a structured approach to executive and director compensation.
• The director's direct beneficial ownership of 40,363 shares indicates a substantial personal investment in the company.

Risks

• The value of the RSU award is dependent on the company's stock price, which can be volatile.
• Vesting is contingent on continued service and adherence to forfeiture and termination provisions, meaning the award could be lost under certain circumstances.
• The award is subject to the company's performance and the outcome of future annual stockholder meetings.

Future Outlook

The restricted stock units granted will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to specified provisions.

Industry Context

StockSavvy.ai notes that equity awards to directors are a common practice in the healthcare technology sector to incentivize long-term performance and align management interests with shareholders. The structure of this award, tied to stock price and vesting over time, is typical for companies seeking to retain key leadership.

Corporate Governance

Stakeholder Impact

• Shareholders: The equity award aligns director interests with long-term shareholder value, but the dilutive effect of RSUs should be considered.
• Employees: The existence of an Omnibus Incentive Plan suggests a broader compensation strategy that may extend to other employees.
• Management: The award is a form of compensation for the director's service.

Next Steps

• The restricted stock units will vest on the date of the Issuer's 2027 annual stockholder meeting.
• The company will continue to operate under its 2025 Omnibus Incentive Plan.

Key Dates

Keywords

NRC Health, Form 4, Insider Trading, Equity Award, Restricted Stock Units, Director Compensation, Omnibus Incentive Plan, Beneficial Ownership